February 21, 2007 (New Orleans) — A new study suggests that botulinum toxin A (Botox, Allergan) may be helpful in treating refractory headache syndrome (RHS). A retrospective review of patients receiving this treatment showed a reduction in the number and duration of headaches in patients with chronic migraines, daily headaches, and cervicalgia headaches who had failed conventional treatment